Snake Venom PLA 2 , a Promising Target for Broad-Spectrum Antivenom Drug Development
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Snakebite envenomation is a neglected global health problem, causing substantial mortality, disability, and psychological morbidity, especially in rural tropical and subtropical zones. Antivenin is currently the only specific medicine for envenomation. However, it is restricted by cold storage, snakebite diagnosis, and high price. Snake venom phospholipase A 2 s (svPLA 2 s) are found in all kinds of venomous snake families (e.g., Viperidae, Elapidae, and Colubridae). Along with their catalytic activity, svPLA 2 s elicit a wide variety of pharmacological effects that play a pivotal role in envenomation damage. Hence, neutralization of the svPLA 2 s could weaken or inhibit toxic damage. Here we overviewed the latest knowledge on the distribution, pathophysiological effects, and inhibitors of svPLA 2 s to elucidate the potential for a novel, wide spectrum antivenom drug targeting svPLA 2 s.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 SDS-PAGE profile of major venom components in the main clades of venomous snakes (adapted from [20]). (a) Families: Elapidae, subfamilies Elapinae, Laticaudinae, Hydrophiinae, and Colubrinae. (b) Family: Viperidae, and subfamilies: Crotalinae (C) and Viperinae (V). Ovals enclose some bands that are typical of protein families, based on published mass. (?) indicates hypothetical protein family or activity.](https://figures.cochat.ai/paper-figures/75223b9f6ce04521a353772cd4263c61/snake-venom-pla-sub-2-sub-a-promising-target-for-broad-spectrum-antivenom-drug-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Snake venom phospholipase A2 (svPLA2) is one of the most abundant toxin families in snake venom and plays a central role in snakebite envenomation.”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“It hydrolyzes the phospholipids of the cell membrane at the sn-2 position of the glycerophospholipids, thereby releasing free fatty acids and lysophospholipids [9].”
From Role of Regulated Cell Death Pathways in Snakebite Envenomation: Mechanisms, Crosstalk, and Therapeutic Opportunities (2026) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The expanding superfamily of phospholipase A2 enzymes: classification and characterization
Six, D. A., & Dennis, E. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00105-0 · Cited by 1,358 · cited 2×
“InGroup I there are approximately 115–120 residues, 7 disulfide bonds (the unique disulfide linking residues 11 and 77), and G IA has a characteristic surface loop between residues 63 to 67 called elapidic loop [11].”
BackgroundDennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V., & Kokotos, G. (2011) · Chemical Reviews · doi:10.1021/cr200085w · Cited by 1,203
Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
Mishra, L. C., Singh, B. B., & Dagenais, S. (2000) · PubMed · Cited by 1,173
The phospholipase A2 superfamily and its group numbering system
Schaloske, R. H., & Dennis, E. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.07.011 · Cited by 936
Snake-bites: appraisal of the global situation.
Chippaux, J. (1998) · Europe PMC (PubMed Central) · Cited by 932
Warrell, D. A. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61754-2 · Cited by 774
Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes
Manjunatha Kini, R. (2003) · Toxicon · doi:10.1016/j.toxicon.2003.11.002 · Cited by 720 · cited 1×
“The diverse toxic effects are tightly related to the multiple functional sites on the surface of svPLA2s and their different binding receptors [25].”
BackgroundConfronting the Neglected Problem of Snake Bite Envenoming: The Need for a Global Partnership
Gutiérrez, J. M., Theakston, R. D. G., & Warrell, D. A. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030150 · Cited by 555
Gutiérrez, J. M., & Ownby, C. L. (2003) · Toxicon · doi:10.1016/j.toxicon.2003.11.005 · Cited by 444 · cited 12×
“These nonimmunoglobulin antitoxins are PLA2 inhibitors (i.e., snake blood phospholipase A2 inhibitors, sbPLIs) and are used to protect the snake from the internal or external envenomation. sbPLIs can be produced by snakes of the Elapidae, Viperidae, Hydrophidae, Colubridae and Boidae families.”
BackgroundInfluentialSnakebite envenoming from a global perspective: Towards an integrated approach
Gutiérrez, J. M., Williams, D., Fan, H. W., & Warrell, D. A. (2010) · Toxicon · doi:10.1016/j.toxicon.2009.11.020 · Cited by 355
Montecucco, C., Gutiérrez, J. M., & Lomonte, B. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8113-3 · Cited by 288 · cited 1×
“Both achieve a similar cellular lesion through membrane perturbation, cytosolic Ca homoeostasis imbalance, and cell degeneration [60].”
BackgroundAnticoagulant proteins from snake venoms: structure, function and mechanism
Kini, R. M. (2006) · Biochemical Journal · doi:10.1042/bj20060302 · Cited by 279 · cited 1×
“The hydrolysis of phospholipids by svPLA2 would be the primary mechanism to account for PLA2s’ anticoagulation [66].”
BackgroundCloning and expression of a membrane receptor for secretory phospholipases A2.
Lambeau, G., Ancian, P., Barhanin, J., & Lazdunski, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42060-6 · Cited by 279
Adverse reactions to snake antivenom, and their prevention and treatment
de Silva, H. A., Ryan, N. M., & de Silva, H. J. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12739 · Cited by 271 · cited 1×
“, anaphylaxis, pyrogenic reactions, and serum sickness) occur in some cases [5].”
Phospholipases A2: Unveiling the secrets of a functionally versatile group of snake venom toxins
Gutiérrez, J. M., & Lomonte, B. (2013) · Toxicon · doi:10.1016/j.toxicon.2012.09.006 · Cited by 260
Neurotoxicity in Snakebite—The Limits of Our Knowledge
Ranawaka, U. K., Lalloo, D. G., & de Silva, H. J. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002302 · Cited by 245 · cited 2×
“Their toxicity varies greatly among species, ranging from 1 μg/kg (Textilotoxin) to 380μg/kg (HDP-2 from Vipera nikolskii) [53].”
Otero, R., Gutiérrez, J., Beatriz Mesa, M., Duque, E., Rodrı́guez, O., Luis Arango, J., Gómez, F., Toro, A., Cano, F., Marı́a Rodrı́guez, L., et al. (2002) · Toxicon · doi:10.1016/s0041-0101(02)00104-6 · Cited by 245 · cited 2×
“This damage is limited to the region where the toxin is injected and is often coupled with hemorrhaging, blistering, and edema [57, 59].”
BackgroundMedicinal Plants with Inhibitory Properties Against Snake Venoms
Soares, A. M., Ticli, F. K., Marcussi, S., Lourenco, M. V., Januario, A. H., Sampaio, S. V., Giglio, J. R., Lomonte, B., & Pereira, P. S. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774370655 · Cited by 244 · cited 1×
“Medicinal plant extracts as traditional antidotes have long been used in countries where the urotherapy is unobtainable [71].”
BackgroundKini, R. M. (2005) · Toxicon · doi:10.1016/j.toxicon.2005.02.018 · Cited by 238
Lewin, M., Samuel, S., Merkel, J., & Bickler, P. (2016) · Toxins · doi:10.3390/toxins8090248 · Cited by 224 · cited 3×
“Indeed, the IC50 values ranged from nano- to picomolars in an in vitro experiment [97].”
BackgroundMethodInfluentialLomonte, B., Moreno, E., Tarkowski, A., Hanson, L. A., & Maccarana, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43961-0 · Cited by 224
Snake venom Lys49 myotoxins: From phospholipases A2 to non-enzymatic membrane disruptors
Lomonte, B., & Rangel, J. (2012) · Toxicon · doi:10.1016/j.toxicon.2012.02.007 · Cited by 186 · cited 4×
“There are also other amino acid substitutions, such as Ser49, Arg49, Asn49, or Gln49 [56].”
BackgroundInfluentialCrotoxin: Novel activities for a classic β-neurotoxin
Sampaio, S. C., Hyslop, S., Fontes, M. R. M., Prado-Franceschi, J., Zambelli, V. O., Magro, A. J., Brigatte, P., Gutierrez, V. P., & Cury, Y. (2010) · Toxicon · doi:10.1016/j.toxicon.2010.01.011 · Cited by 179
Halpert, J., & Eaker, D. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)41030-2 · Cited by 176
Lambeau, G., Schmid-Alliana, A., Lazdunski, M., & Barhanin, J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38881-7 · Cited by 157
Quirós, S., Alape‐Girón, A., Angulo, Y., & Lomonte, B. (2006) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2006.09.003 · Cited by 153 · cited 1×
“When the target PLA2s are Lys49 homologues or Asp49 myotoxins, the sbPLIs are specifically called myotoxin inhibitor proteins (MIPs) [85, 86].”
Correlation of Enzymatic Activity and Anticoagulant Properties of Phospholipase A2
Verheij, H. M., Boffa, M., Rothen, C., Bryckaert, M., Verger, R., & Haas, G. H. D. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb04982.x · Cited by 150 · cited 1×
“PLA2s can be classified as strong, weak, and nonanticoagulant based on the dose required to inhibit blood coagulation [65].”
BackgroundPungerčar, J., & Križaj, I. (2007) · Toxicon · doi:10.1016/j.toxicon.2007.07.025 · Cited by 145 · cited 1×
“svPLA2 neurotoxicity affects presynaptic nerve terminals, so these compounds are commonly referred as presynaptic neurotoxins or β-neurotoxins (β-ntxs) [54].”
BackgroundThe amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper
Kaiser, I. I., Gutiérrez, J. M., Plummer, D., Aird, S. D., & Odell, G. V. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90266-2 · Cited by 144
Junior, R. M. (1997) · QJM · doi:10.1093/qjmed/90.5.323 · Cited by 138 · cited 1×
“This damage is limited to the region where the toxin is injected and is often coupled with hemorrhaging, blistering, and edema [57, 59].”
BackgroundBorges, M. H., Soares, A. M., Rodrigues, V. D. M., Andrião-Escarso, S. H., Silva, H. D., Hamaguchi, A., Rueda, A. Q., Lizano, S., Gutiérrez, J. M., Giglio, J. R., et al. (2000) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(00)00237-6 · Cited by 136 · cited 1×
“Indeed, this plant has been found to inhibit myotoxicity, hemorrhage, anticoagulation, and edema [75, 76].”
BackgroundNúñez, C. E., Angulo, Y., & Lomonte, B. (2001) · Toxicon · doi:10.1016/s0041-0101(01)00141-6 · Cited by 131 · cited 1×
“Previous studies focused on the fact that amino acids composition of synthetic peptides has revealed that the Cterminal regions of 115–129 residues, which are positively charged and full of basic, aromatic, hydrophobic residues, are the key structure in eliciting myotoxic effects [62, 63].”
BackgroundBorges, M. H., Soares, A. M., Rodrigues, V. D. M., de Oliveira, F., Fransheschi, A. M., Rucavado, A., Giglio, J. R., & Homsi-Brandeburgo, M. I. (2001) · Toxicon · doi:10.1016/s0041-0101(01)00169-6 · Cited by 129 · cited 1×
“Indeed, this plant has been found to inhibit myotoxicity, hemorrhage, anticoagulation, and edema [75, 76].”
BackgroundNatural phospholipase A2 myotoxin inhibitor proteins from snakes, mammals and plants
Lizano, S., Domont, G. B., & Perales, J. (2003) · Toxicon · doi:10.1016/j.toxicon.2003.11.007 · Cited by 115 · cited 1×
“These sbPLIs can be classified into three groups based on the homology of their amino acid sequence: α, β and γ [84].”
BackgroundWard, R. J., Chioato, L., de Oliveira, A. H. C., Ruller, R., & Sá, J. M. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3620089 · Cited by 113
Soares, A. M., Rodrigues, V. D. M., Homsi-Brandeburgo, M. I., Toyama, M. H., Lombardi, F. R., Arni, R. K., & Giglio, J. R. (1998) · Toxicon · doi:10.1016/s0041-0101(97)00133-5 · Cited by 111
KRIŽAJ, I., BIEBER, A. L., RITONJA, A., & GUBENšEK, F. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16485.x · Cited by 109
Mora-Obando, D., Fernández, J., Montecucco, C., Gutiérrez, J. M., & Lomonte, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109846 · Cited by 104 · cited 1×
“, two different svPLA2s, the “Asp” and “Lys” myotoxins from Bothrops asper, have been shown to synergistically enhance myonecrosis in in vitro and in vivo studies [98]) or other venom components (e.”
BackgroundPhospholipases A2 from viperidae snake venoms: how do they induce skeletal muscle damage?
Lomonte, B., & Gutiérrez, J. M. (2011) · PubMed · Cited by 101
Snake Venom Phospholipase A2 Inhibitors: Medicinal Chemistry and Therapeutic Potential
Marcussi, S., Sant'Ana, C., Oliveira, C., Quintero Rueda, A., Menaldo, D., Beleboni, R., Stabeli, R., Giglio, J., M. Fontes, M., & Soares, A. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780487614 · Cited by 99 · cited 1×
“Due to the high cost, long production period, limited categories, short storage life, and common clinical side-effects of current antivenin, scientists have attempted to create antidotes from herbal extracts, marine compounds, mammalian and snake serum, and modified chemical molecules and peptides [70].”
BackgroundProteome analysis of snake venom toxins: pharmacological insights
Georgieva, D., Arni, R. K., & Betzel, C. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.6.787 · Cited by 94
Therapeutic application of natural inhibitors against snake venom phospholipase A2
Samy, R. P., Gopalakrishnakone, P., & Chow, V. T. K. (2012) · Bioinformation · doi:10.6026/97320630008048 · Cited by 91 · cited 1×
“Indeed, there is sufficient evidence that PLA2 inhibitors (PLIs) are effective in using snake venom envenomation therapy [69].”
BackgroundCavalcante, W. L. G., Campos, T. O., Dal‐Pai‐Silva, M., Pereira, P. S., Oliveira, C. Z., Soares, A. M., & Gallacci, M. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.04.002 · Cited by 90
Ohkura, N., OKUHARA, H., Inoue, S., Ikeda, K., & Hayashi, K. (1997) · Biochemical Journal · doi:10.1042/bj3250527 · Cited by 87
KONDO, K., Toda, H., Narita, K., & Lee, C.-Y. (1982) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a133844 · Cited by 86
Quercetin as an inhibitor of snake venom secretory phospholipase A2
Cotrim, C. A., de Oliveira, S. C. B., Diz-Filho, E. B. S., Fonseca, F. V., Baldissera, L., Antunes, E., Ximenes, R. M., Monteiro, H. S. A., Rabello, M. M., Hernandes, M. Z., et al. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.10.016 · Cited by 82 · cited 1×
“, quercetin, biflavonoid morelloflavone [78, 79]) isolated from plant extracts can also inhibit svPLA2.”
BackgroundStefansson, S., Kini, R. M., & Evans, H. J. (1990) · Biochemistry · doi:10.1021/bi00485a024 · Cited by 77 · cited 1×
“Furthermore, there are other mechanisms that restrain coagulation, such as inhibition of the activation of the conversion of FX (blood coagulation factor X) to FXa (blood coagulation factor Xa) and/or prothrombin to thrombin [68].”
BackgroundKerns, R. T., Kini, R. M., Stefansson, S., & Evans, H. J. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1345 · Cited by 76 · cited 1×
“svPLA2s can also induce other toxic effects such as myoglobinuria-inducing, hemolytic, and platelet aggregation initiating/inhibiting activities [49].”
BackgroundChioato, L., Aragão, E. A., Lopes Ferreira, T., Ivo de Medeiros, A., Faccioli, L. H., & Ward, R. J. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.01.023 · Cited by 71 · cited 1×
“Sitedirectedmutagenesis experiments proved that Tyr117, Arg118, Tyr119, Lys122, and Phe125 also have significant impacts on myotoxicity [64].”
BackgroundZiganshin, R., Kovalchuk, S. I., Arapidi, G. P., Starkov, V. G., Hoang, A. N., Nguyen, T. T. T., Nguyen, K. C., Shoibonov, B. B., Tsetlin, V. I., & Utkin, Y. N. (2015) · Toxicon · doi:10.1016/j.toxicon.2015.08.026 · Cited by 71 · cited 1×
“However, Bungarus fasciatus venom was found to consist of up to 71% of PLA2s [23].”
BackgroundWesterlund, B., Nordlund, P., Uhlin, U., Eaker, D. L., & Eklund, H. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81238-h · Cited by 67
Possani, L. D., Martin, B. M., Yatani, A., Mochca-Morales, J., Zamudio, F. Z., Gurrola, G. B., & Brown, A. M. (1992) · Toxicon · doi:10.1016/0041-0101(92)90511-3 · Cited by 66 · cited 1×
“, taicatoxin, a Ca channel inhibitor composed of an α-neurotoxin-like peptide, a neurotoxic phospholipase A2, and a serine protease inhibitor, connected by noncovalent bonds [99]).”
BackgroundSaikia, D., Thakur, R., & Mukherjee, A. K. (2011) · Toxicon · doi:10.1016/j.toxicon.2011.02.018 · Cited by 66
Rosenson, R. S., Elliott, M. D., Stasiv, Y., Hislop, C., for the PLASMA II Investigators, Imburgia, M., Weiss, R., Underwood, P., Ende, D. J., Brown, C., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq374 · Cited by 66 · cited 1×
“Thought to be an effective antiatherosclerotic agent, varespladib showed promising therapeutic effects in reducing plasma sPLA2 and low-density lipoprotein (LDL) [96].”
BackgroundPearson, J. A., Tyler, M. I., Retson, K. V., & Howden, M. E. H. (1993) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(93)90217-f · Cited by 65 · cited 2×
“While G IB has a five amino acids residues (residues 62–67) extension termed pancreatic loop, some G IB snake venom PLA2 even has an eight-residue propeptide segment in their mature state [13, 16].”
Lizano, S., Lomonte, B., Fox, J. W., & GUTIÉRREZ, J. M. (1997) · Biochemical Journal · doi:10.1042/bj3260853 · Cited by 65
A High Affinity Acceptor for Phospholipase A2 with Neurotoxic Activity Is a Calmodulin
Šribar, J., Čopič, A., Pariš, A., Sherman, N. E., Gubenšek, F., Fox, J. W., & Križaj, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100048200 · Cited by 65
Phospholipase A2 inhibition and modification by manoalogue
Reynolds, L. J., Morgan, B. P., Hite, G. A., Mihelich, E. D., & Dennis, E. A. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00223a044 · Cited by 62
Fohlman, J., Lind, P., & Eaker, D. L. (1977) · FEBS Letters · doi:10.1016/0014-5793(77)80726-6 · Cited by 62 · cited 1×
“There are also group IB enzymes which are mainly found in mammalian pancreas that have been reported in some snake venoms, such as Oxyuranus scutellatus [12], Pseudonaja textilis [13], and Micrurus frontalis frontalis [14].”
BackgroundJoubert, F. J. (1977) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(77)90275-6 · Cited by 62
Francis, B. R., da Silva, N. J., Seebart, C. S., Casais-e-Silva, L. L., Schmidt, J. J., & Kaiser, I. I. (1997) · Toxicon · doi:10.1016/s0041-0101(97)00031-7 · Cited by 60 · cited 1×
“There are also group IB enzymes which are mainly found in mammalian pancreas that have been reported in some snake venoms, such as Oxyuranus scutellatus [12], Pseudonaja textilis [13], and Micrurus frontalis frontalis [14].”
BackgroundFaure, G., Gowda, V. T., & Maroun, R. C. (2007) · BMC Structural Biology · doi:10.1186/1472-6807-7-82 · Cited by 58
Differential effects of manoalide on secreted and intracellular phospholipases
Bennett, C. F., Mong, S., Clarke, M. A., Kruse, L. I., & Crooke, S. T. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90727-1 · Cited by 57
da Rocha, S. B., Lomonte, B., Neves‐Ferreira, A. G. C., Trugilho, M. R. O., Junqueira-de-Azevedo, I. L. M., Ho, P. L., Domont, G. B., Gutiérrez, J. M., & Perales, J. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03308.x · Cited by 56
Ponce-Soto, L. A., Lomonte, B., Gutiérrez, J. M., Α, L. R.-S., Novello, J. C., & Marangoni, S. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.11.015 · Cited by 54
Pereañez, J. A., Patiño, A. C., Núñez, V., & Osorio, E. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.06.015 · Cited by 48 · cited 1×
“, quercetin, biflavonoid morelloflavone [78, 79]) isolated from plant extracts can also inhibit svPLA2.”
BackgroundSutcliffe, M. J., Dobson, C. M., & Oswald, R. E. (1992) · Biochemistry · doi:10.1021/bi00126a017 · Cited by 48
Structural and Pharmacological Features of Phospholipases A2 from Snake Venoms
Cisne, R., Castro, H. C., Rodrigues, C., Melo, P., & Fuly, A. (2009) · Protein and Peptide Letters · doi:10.2174/092986609788923365 · Cited by 48 · cited 1×
“These compounds are conserved in structure andhave similar molecular masses (∼10–20 kDa), 5–7 disulfide bonds, and analogous three-dimensional structures [15].”
BackgroundAlmeida, J. R., Lancellotti, M., Soares, A. M., Calderón, L. A., Ramírez, D., González, W., Marangoni, S., & Silva, S. L. D. (2016) · Toxicon · doi:10.1016/j.toxicon.2016.08.007 · Cited by 47
Šribar, J., Sherman, N. E., Prijatelj, P., Faure, G., Gubenšek, F., Fox, J. W., Aitken, A., Pungerčar, J., & Križaj, I. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00228-6 · Cited by 45
Petan, T., Križaj, I., & Pungerčar, J. (2007) · Biochemistry · doi:10.1021/bi701304e · Cited by 43
Terra, A. L. C., Moreira-Dill, L. S., Simões‐Silva, R., Monteiro, J. R. D. N., Cavalcante, W. L. G., Gallacci, M., Barros, N. B. D., Nicolete, R., Teles, C. B. G., Medeiros, P. S. M., et al. (2015) · Toxicon · doi:10.1016/j.toxicon.2015.06.011 · Cited by 42
Machiah, D. K., & Gowda, T. V. (2006) · Biochimie · doi:10.1016/j.biochi.2005.12.006 · Cited by 42 · cited 1×
“WSG has a similar structure to the α-chain of the PLIs derived from Australian elapid serum and was found to interact with NN-XIa–PLA2, but the mechanism currently remains unknown [74].”
BackgroundMundekkad, D., & Gowda, T. V. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00527-1 · Cited by 39
Ammodytoxins, Potent Presynaptic Neurotoxins, Are Also Highly Efficient Phospholipase A2Enzymes
Petan, T., Križaj, I., Gelb, M. H., & Pungerčar, J. (2005) · Biochemistry · doi:10.1021/bi051024r · Cited by 37 · cited 1×
“, phosphatidylserine, phosphatidic acid, and phosphorylated phosphatidylinositols) which are abundant in the cytosolic leaflets of organelles and the plasmamembrane of eukaryotic cells [55].”
BackgroundSharma, M., Iyer, J. K., Shih, N., Majumder, M., Mattaparthi, V. S. K., Mukhopadhyay, R., & Doley, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153770 · Cited by 35
Luca, D. D., Minucci, A., Trias, J., Tripodi, D., Conti, G., Zuppi, C., Capoluongo, E., & On behalf of the Study Group on Secretory Phospholipase in Pediatrics (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011405498 · Cited by 33 · cited 1×
“From 2006 to 2012, varespladib was under active investigation by Anthera Pharmaceuticals for using as a potential therapy for several inflammatory diseases, including acute coronary syndrome and acute chest syndrome [94, 95].”
MethodSnake bite—the neglected tropical disease
Lancet, T. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00247-0 · Cited by 33 · cited 1×
“Unfortunately, snakebite was neglected by governments and international health agencies for a long time, even though the snake bite mortality rate is equivalent to one-fifth of the deaths from malaria worldwide and half of the deaths from HIV/AIDS in India [3].”
BackgroundAfrica braced for snakebite crisis
Schiermeier, Q. (2015) · Nature · doi:10.1038/525299a · Cited by 27 · cited 2×
“This has resulted in a large-scale snakebite crisis in rural Africa [7].”
BackgroundOliveira, C. Z., Santos‐Filho, N. A., Menaldo, D. L., Boldrini-França, J., Giglio, J. R., Calderón, L. A., Stábeli, R. G., Rodrigues, F. H. S., Tasić, L., Silva, S. L. D., et al. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611797633465 · Cited by 25
Karakas, M., & Köenig, W. (2009) · PubMed · Cited by 25
Vardjan, N., Sherman, N. E., Pungerčar, J., Fox, J. W., Gubenšek, F., & Križaj, I. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5940 · Cited by 22
Rodríguez, J. P., Marzi, M. C. D., Maruñak, S. L., Malchiodi, E. L., Leiva, L. C., & Acosta, O. (2006) · PubMed · Cited by 21
Le, Z., Li, X., Yuan, P., Liu, P., & Huang, C. (2015) · Toxicon · doi:10.1016/j.toxicon.2015.10.018 · Cited by 20
Self-citationXiong, S., Luo, Y., Zhong, L., Xiao, H., Pan, H., Liao, K., Yang, M., & Huang, C. (2017) · Toxicon · doi:10.1016/j.toxicon.2017.07.019 · Cited by 19 · cited 1×
“sbPLIs are natural, endogenous protective components against snake venom, among which the γPLI were commonly inhibitive to different category of venoms [100].”
BackgroundSelf-citationChakraborty, A. K., HALL, R. H., & Ghose, A. C. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1016591318855 · Cited by 18
León, I. R., Neves‐Ferreira, A. G. C., da Rocha, S. B., Trugilho, M. R. O., Perales, J., & Valente, R. H. (2012) · PROTEOMICS · doi:10.1002/pmic.201200062 · Cited by 17 · cited 1×
“N-glycosylation sites (Asn46, Asn179, Asn183, and Asn379) in this antimyotoxic protein play important roles in this inhibitory action [83].”
BackgroundCoulter, A. R., Harris, R. D., Broad, A. J., Sutherland, S. K., Sparrow, L. G., Misconi, L., Hamilton, R., & Rubira, M. R. (1983) · Toxicon · doi:10.1016/0041-0101(83)90160-5 · Cited by 16
Bonfim, V. L., Ponce-Soto, L. A., Martins‐de‐Souza, D., Souza, G. H. M. F., Baldasso, P. A., Eberlin, M. N., & Marangoni, S. (2008) · Biologicals · doi:10.1016/j.biologicals.2007.10.004 · Cited by 14
Proteomics in Venom Research: a Focus on PLA2 Molecules.
Calvete, J. J. (2011) · PubMed · Cited by 12
Fusco, L., Rodríguez, J. P., Torres-Huaco, F. D., Huancahuire‐Vega, S., Teibler, P., Acosta, O., Marangoni, S., Ponce-Soto, L. A., & Leiva, L. C. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.06.528 · Cited by 11 · cited 1×
“Anti-PLA2 antibodies could specifically inactivate enzymatic activity and toxicity, both with the original venom and other svPLA2s [93].”
BackgroundBonfim, V. L., Ponce-Soto, L. A., Novello, J. C., & Marangoni, S. (2006) · The Protein Journal · doi:10.1007/s10930-006-9033-4 · Cited by 11
Neutralisation of the pharmacological activities of Bothrops alternatus venom by anti-PLA2 IgGs
Denegri, M. E. G., Maruñak, S. L., Todaro, J. S., Ponce-Soto, L. A., Acosta, O., & Leiva, L. C. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.05.016 · Cited by 8 · cited 1×
“developed a polyantibody using a nontoxic PLA2 (BaSpII RP4) from Bothrops alternatus as antigen [91].”
MethodPharmacological study on phospholipases A2 isolated from Naja mossambica mossambica venom.
Lin, W., Pl, C., Lee, C., & Fj, J. (1987) · PubMed · Cited by 7
Research works printed but not linked: 12
- 1998, Bulletin of the World Health Organization, 76, 515
- 1997, Phospholipase A2 structure and catalytic properties, 97
- 2010, Snake Venom Phospholipase A2 Enzymes, 174
- 1997, Multicomponent neurotoxic phospholipases A2, 269
- 2010, The field of reptile toxinology snakes, lizards, and their venoms, 3
- 2011, Acta Chimica Slovenica, 58, 629
- 1987, Proceedings of the National Science Council, Republic of China, Part B, Life Sciences, 11, 155
- 2011, Acta Chimica Slovenica, 58, 647
- 2000, Alternative Medicine Review, 5, 334
- 2011, Pharmaceutical Biotechnology, 18, 220
- 2006, Medicina, 66, 512
- 2009, IDrugs, 12, 585
Cited by
Senji Laxme, R. R., Khochare, S., de Souza, H. F., Ahuja, B., Suranse, V., Martin, G., Whitaker, R., & Sunagar, K. (2019) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0007899 · Cited by 195
“While the mechanism of action of some of the snake venom toxins have been extensively studied [70, 79, 80], others, especially the least abundant toxins, remain chiefly underinvestigated.”
BackgroundCytotoxicity of snake venom enzymatic toxins: phospholipase A2 and l -amino acid oxidase
Hiu, J. J., & Yap, M. K. K. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200110 · Cited by 149
Catalytically Active Snake Venom PLA 2 Enzymes: An Overview of Its Elusive Mechanisms of Reaction
Castro-Amorim, J., de Oliveira, A. L. N., Silva, S. L. D., Soares, A. M., Mukherjee, A. K., Ramos, M. J., & Fernandes, P. A. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00097 · Cited by 97
Lewin, M. R., Carter, R. W., Matteo, I. A., Samuel, S. P., Rao, S., Fry, B. G., & Bickler, P. E. (2022) · Toxins · doi:10.3390/toxins14110783 · Cited by 94
Hypotensive Snake Venom Components—A Mini-Review
Péterfi, O., Boda, F., Szabó, Z., Ferencz, E., & Bába, L.-I. (2019) · Molecules · doi:10.3390/molecules24152778 · Cited by 91
“Snake venom PLA2s are present in the venoms of species from the Colubridae, Elapidae and Viperidae snake families and they are one of the major toxic components with a wide spectrum of pharmacological effects [94].”
Background
Metadata
- Authors
- Xiao, H., Pan, H., Liao, K., Yang, M., & Huang, C.
- Affiliations
- Nanchang University (CN)
- Corresponding author
- Huang, Chunhong
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2017
- Volume
- 2017
- Pages
- 1-10
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC5727668
- OpenAlex
- W2773445094
- Cited by
- 113
- References
- 95
- Citations by year
- 2026: 19 · 2025: 16 · 2024: 16 · 2023: 13 · 2022: 15 · 2021: 5 · 2020: 10 · 2019: 11 · 2018: 8
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BioMed Research International (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (31260209, 31460227, 20171BAB204015, 20171BCB23018)
- Natural Science Foundation of Jiangxi Province (31260209, 31460227, 20171BAB204015, 20171BCB23018)
- Cultivating Foundation of Young Scientists of Jiangxi Province (31260209, 31460227, 20171BAB204015, 20171BCB23018)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Venomous Animal Envenomation and Studies
- Health Sciences › Medicine › Pharmacology (medical) › Healthcare and Venom Research
- Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Amphibian and Reptile Biology
- Keywords
- snake venom phospholipase A2, snakebite, venomous snakes, Viperidae, Elapidae, Colubridae
- MeSH terms
- Animals, Antivenins, Drug Stability, Humans, Snake Venoms, Phospholipases A2, Phospholipase A2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.